Review
Open access
Sep 2026
Beyond pCR Prediction: Subtype-Specific Artificial Intelligence for Treatment Tailoring in Breast Cancer Neoadjuvant Therapy
Current evidence is not strong enough for AI to change an individual treatment or surgery decision safely, and models used to estimate response are not interchangeable across subtypes and must be read in their original treatment context.
Jun-Wen Zhou, Bei-Bei Xi, Ke-Huan Yan et al.
· Cancers · 0 citations